Ignite Creation Date:
2025-12-25 @ 1:03 AM
Ignite Modification Date:
2025-12-26 @ 1:40 PM
Study NCT ID:
NCT00899093
Status:
TERMINATED
Last Update Posted:
2018-05-22
First Post:
2009-05-09
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
YKL-40 in Serum Samples From Patients With Newly Diagnosed Stage III-IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer Receiving Chemotherapy
Sponsor:
Gynecologic Oncology Group
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-09
Start Date Type:
None
Primary Completion Date:
2016-06
Primary Completion Date Type:
ACTUAL
Completion Date:
None
Completion Date Type:
None
First Submit Date:
2009-05-09
First Submit QC Date:
None
Study First Post Date:
2009-05-12
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-05-21
Last Update Post Date:
2018-05-22
Last Update Post Date Type:
ACTUAL